Epidemiological characteristics of patients with Covid-19suspicion applying to a university hospital: The first eightydays in a pandemic

Aim: The first COVID-19 case in Turkey was detected on March 11, 2020 during the COVID-19 pandemic process. Epidemiologicalstudies are needed to be prepared for other outbreaks and to be effective in the disease management process. Based on this reason,in this study it was aimed to determine the epidemiological characteristics of Covid 19 possible and definite cases who applied tothe university hospital during the pandemic process. Materials and Methods: This retrospective epidemiological study was carried out by analyzing the data of Covid 19 possible anddefinite cases, who applied to the university hospital operating as a pandemic hospital between 11 March / 01 June 2020. The datawere summarized with descriptive statistics, tables and graphs. Results: Of the 1,383 patients, who applied with the suspicion of COVID-19, 55.5% were men and 84.5% were adults. The medianage of children is 4.0 (1.5-10) years old; adults were 52.0 (36.0-67.0) years old. The median time between the outset of complaintsand the date of admission to the hospital was 2 (1-3) days. 87.4% of adults and 87.9% of children had symptoms that supportedCOVID-19 infection. Among cases 7.8% were health care workers. The median age of the fatal cases was 71 (64-82) years old, 79.5%were male, 77.7% were retired. The most common comorbide diseases in these cases were hypertension (28.2%) and malignancy(28.2%). The case fatality rate was found as 2.8% in all patients and 48.4% in patients hospitalized in the intensive care unit.Conclusions: As a result, Covid-19 affects all age groups. Hypertension and malignancy were the most common additional diseasesin fatal cases. The risk of illness is higher in healthcare workers who have direct contact with the patients. According to ourobservations, preventive measures, rapid diagnosis and supportive treatment are valuable.

PDF

___

1. ECDC, Novel coronavirus. https://www.ecdc. europa.eu/en/novel-coronavirus-china access date 01.06.2020
2. WHO, Novel Coronavirus (2019-nCoV) Situation Report – 13. https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200202- sitrep-13-ncov-v3.pdf?sfvrsn=195f4010_6 access date 01.06.2020
3. WHO, Director-General's opening remarks at the media briefing on COVID-19-11 March 2020 https://www. who.int/dg/speeches/detail/who-director-generals-opening-remarks-at-the-media-briefing-on-covid19---11-march-2020 access date 01.06.2020
4. Mese S, Agacfidan A. Coronavirus: General Features and Current Approach. SABİAD 2020;3:14-23.
5. International Committee on Taxonomy of Viruses (ICTV). Taxonomic Information. https://talk. ictvonline.org/taxonomy/ access date 01.06.2020
6. T.C. Sağlık Bakanlığı Covid-19 Rehberi. https:// covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_ Rehberi.pdf access date 01.06.2020
7. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel corona virus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-13.
8. McIntosh K. Coronavirusdisease 2019 (COVID-19): Clinicalfeatures. In T.W Post Hirsch M S, BloomA, Uptodate. https://www.uptodate. com/contents/coronavirus-disease-2019- covid-19-clinical-features?search=covid%20 19&topicRef=126981&source=related_link access date 01.06.2020
9. Fang Y, Zhang H, Xie J, et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology 2020; 296:115-7.
10. Issever H, Issever T, Oztan G. Epidemiology of COVID-19. Sağlık Bilimlerinde İleri Araştırmalar Dergisi 2020; 3(Suppl.1): 1-13. https://doi.org/10.26650/ JARHS2020-S1-0001
11. Unuvar A. COVID-19 and Coagulopathy. SABİAD 2020;3:53-62.
12. WHO. Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019- nCoV in humans. https://www.who.int/ emergencies/diseases/novelcoronavirus-2019/ technical-guidance/laboratoryguidance access date 01.06.2020
13. T.C Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, 2019-nCoV Hastalığı Rehberi (Bilim Kurulu Çalışması). https://covid19bilgi.saglik.gov.tr/depo/rehberler/ COVID-19_Rehberi access date 01.06.2020
14. Li Z, Yi Y, Luo X et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol 2020;92:1518-24.
15. US Food and Drug Administration. Emergency Use Authorizations. https://www.fda.gov/ emergencypreparedness-and-response/ coronavirus-disease2019-covid-19/coronavirusdisease-2019-covid-19- frequently-askedquestions access date 01.06.2020
16. CDC, Prevention and Treatment. https://www.cdc. gov/coronavirus/ about/prevention.html access date 01.06.2020.
17. Nikpouraghdam M, Farahani AJ, Alishiri GH, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J ClinVirology 2020;127:104378
18. Ge H, Wang X, Yuan X, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis 2020;39:1011-9.
19. Flourish Studio. https://public.flourish.studio/ visualisation/3312652/, https://public.flourish. studio/visualisation/3312130/, access date 10.10.2020.
20. WHO, Coronavirusdisease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/ novel-coronavirus-2019/situation-reports access date 01.06.2020.
21. T.C. Sağlık Bakanlığı Türkiye Günlük Koronavirüs Tablosu. https://covid19.saglik.gov.tr access date 01.06.2020.
22. Richardson S, Hirsch JS, Narasimhan M et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the NewYork City Area. JAMA 2020;323:2052-9.
23. Feng Y, Ling Y, Bai T et al. COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med 2020;201:1380-8.
24. Götzinger F, Santiago-García B, Noguera-Julián A et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health 2020;4:653-61.
25. Wang R, Pan M, Zhang X et al. Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China. Int J Inf Dis 2020;95:421-8.
26. Yayla Ceylan CB, Ozsurekci Y, Aykac K, et al. Characteristics and Management of Children with COVID-19 in Turkey. Balkan Med J 2020;37:341-7.
27. Popescu CP, Marin A, Melinte V, et al. COVID-19 in a tertiary hospital from Romania: Epidemiology, preparedness and clinical challenges. Travel Med Infect Dis 2020;35:101662.
28. Lai X, Wang M, Qin C, et al. Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China. JAMA Netw Open 2020;3:209666.
29. Bernheim A, Mei X, Huang M, et al. Chest CT Findings in CoronavirusDisease 2019 (COVID-19): Relationship to Duration of Infection. Radiology 2020;295:685-91.
30. WHO Coronavirusdisease 2019 (COVID-19) Situation report – 133. https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200601- covid-19-sitrep-133.pdf?sfvrsn=9a56f2ac_4 access date 01.06.2020.